These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

259 related items for PubMed ID: 25946355

  • 21. Are we justified in treating for multidrug-resistant tuberculosis based on positive follow-up smear results?
    Kumar RS, Kumar AM, Claassens M, Banurekha VV, Sekar G, Venkatesan P, Swaminathan S.
    Int J Tuberc Lung Dis; 2014 Apr; 18(4):449-53. PubMed ID: 24670701
    [Abstract] [Full Text] [Related]

  • 22. Active contact investigation and treatment support: an integrated approach in rural and urban Sindh, Pakistan.
    Shah SA, Qayyum S, Abro R, Baig S, Creswell J.
    Int J Tuberc Lung Dis; 2013 Dec; 17(12):1569-74. PubMed ID: 24200270
    [Abstract] [Full Text] [Related]

  • 23. Trend in the incidence of smear-positive tuberculosis in a district in South India after DOTS implementation.
    Subramani R, Gomathy S, Lakshmi M, Swaminathan S.
    Int J Tuberc Lung Dis; 2016 Aug; 20(8):1022-6. PubMed ID: 27393534
    [Abstract] [Full Text] [Related]

  • 24. Predictors of delayed sputum smear conversion among pulmonary tuberculosis patients in Kota Kinabalu, Malaysia: A retrospective cohort study.
    Mokti K, Md Isa Z, Sharip J, Abu Bakar SN, Atil A, Hayati F, Syed Abdul Rahim SS.
    Medicine (Baltimore); 2021 Aug 06; 100(31):e26841. PubMed ID: 34397855
    [Abstract] [Full Text] [Related]

  • 25. Predictors of sputum culture conversion among patients treated for multidrug-resistant tuberculosis.
    Kurbatova EV, Gammino VM, Bayona J, Becerra MC, Danilovitz M, Falzon D, Gelmanova I, Keshavjee S, Leimane V, Mitnick CD, Quelapio MI, Riekstina V, Taylor A, Viiklepp P, Zignol M, Cegielski JP.
    Int J Tuberc Lung Dis; 2012 Oct 06; 16(10):1335-43. PubMed ID: 23107633
    [Abstract] [Full Text] [Related]

  • 26. Incomplete sputum smear microscopy monitoring among smear-positive tuberculosis patients in Uganda.
    Nakaggwa P, Odeke R, Kirenga BJ, Bloss E.
    Int J Tuberc Lung Dis; 2016 May 06; 20(5):594-9. PubMed ID: 27084811
    [Abstract] [Full Text] [Related]

  • 27. Predictors and mortality associated with treatment default in pulmonary tuberculosis.
    Kliiman K, Altraja A.
    Int J Tuberc Lung Dis; 2010 Apr 06; 14(4):454-63. PubMed ID: 20202304
    [Abstract] [Full Text] [Related]

  • 28. Longer delay in accessing treatment among current smokers with new sputum smear-positive tuberculosis in Nepal.
    Bam TS, Enarson DA, Hinderaker SG, Bam DS.
    Int J Tuberc Lung Dis; 2012 Jun 06; 16(6):822-7. PubMed ID: 22507563
    [Abstract] [Full Text] [Related]

  • 29. Smear-negative, culture-positive pulmonary tuberculosis among patients with chronic cough in Cotonou, Benin.
    Affolabi D, Akpona R, Odoun M, Alidjinou K, Wachinou P, Anagonou S, Gninafon M, Trébucq A.
    Int J Tuberc Lung Dis; 2011 Jan 06; 15(1):67-70. PubMed ID: 21276299
    [Abstract] [Full Text] [Related]

  • 30. Association of conversion & cure with initial smear grading among new smear positive pulmonary tuberculosis patients treated with Category I regimen.
    Gopi PG, Chandrasekaran V, Subramani R, Santha T, Thomas A, Selvakumar N, Narayanan PR.
    Indian J Med Res; 2006 Jun 06; 123(6):807-14. PubMed ID: 16885603
    [Abstract] [Full Text] [Related]

  • 31. Role of pharmaceutical care for self-administered pulmonary tuberculosis treatment in Thailand.
    Tanvejsilp P, Pullenayegum E, Loeb M, Dushoff J, Xie F.
    J Clin Pharm Ther; 2017 Jun 06; 42(3):337-344. PubMed ID: 28317143
    [Abstract] [Full Text] [Related]

  • 32. Tuberculosis control in Bangladesh: success of the DOTS strategy.
    Kumaresan JA, Ahsan Ali AK, Parkkali LM.
    Int J Tuberc Lung Dis; 1998 Dec 06; 2(12):992-8. PubMed ID: 9869115
    [Abstract] [Full Text] [Related]

  • 33. Diabetes mellitus and tuberculosis: pattern of tuberculosis, two-month smear conversion and treatment outcomes in Guangzhou, China.
    Mi F, Tan S, Liang L, Harries AD, Hinderaker SG, Lin Y, Yue W, Chen X, Liang B, Gong F, Du J.
    Trop Med Int Health; 2013 Nov 06; 18(11):1379-85. PubMed ID: 24112411
    [Abstract] [Full Text] [Related]

  • 34. The DOTS strategy for treatment of paediatric pulmonary tuberculosis in South Delhi, India.
    Sharma S, Sarin R, Khalid UK, Singla N, Sharma PP, Behera D.
    Int J Tuberc Lung Dis; 2008 Jan 06; 12(1):74-80. PubMed ID: 18173881
    [Abstract] [Full Text] [Related]

  • 35. Implementation fidelity of hospital based directly observed therapy for tuberculosis treatment in Bhutan: mixed-method study.
    Dorji K, Lestari T, Jamtsho S, Mahendradhata Y.
    BMC Public Health; 2020 Apr 19; 20(1):533. PubMed ID: 32306977
    [Abstract] [Full Text] [Related]

  • 36. DOT and timely treatment completion among Asian-born immigrant tuberculosis patients.
    Liu SY, Li JH, Schluger NW.
    Int J Tuberc Lung Dis; 2005 Aug 19; 9(8):884-9. PubMed ID: 16104635
    [Abstract] [Full Text] [Related]

  • 37. Five year review of treatment outcome of directly observed therapy (DOT) for re-treatment pulmonary tuberculosis patients in UCH, Ibadan, Nigeria.
    Ige OM, Akindele MO.
    Afr J Med Med Sci; 2011 Mar 19; 40(1):15-21. PubMed ID: 21834257
    [Abstract] [Full Text] [Related]

  • 38. API TB Consensus Guidelines 2006: Management of pulmonary tuberculosis, extra-pulmonary tuberculosis and tuberculosis in special situations.
    API Consensus Expert Committee.
    J Assoc Physicians India; 2006 Mar 19; 54():219-34. PubMed ID: 16800350
    [Abstract] [Full Text] [Related]

  • 39. Association between Mycobacterium tuberculosis lineage and time to sputum culture conversion.
    Click ES, Winston CA, Oeltmann JE, Moonan PK, Mac Kenzie WR.
    Int J Tuberc Lung Dis; 2013 Jul 19; 17(7):878-84. PubMed ID: 23743308
    [Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 13.